HIV and Heart Disease: Understanding the Connection

For years, HIV infection was considered primarily an immunological threat. However, advances in antiretroviral therapy (ART) have dramatically extended the lifespan of individuals living with HIV, revealing a growing and significant link between HIV and cardiovascular disease (CVD). While ART has been transformative, it hasn’t eliminated the increased risk of heart problems in this population. This article explores the complex relationship between HIV and heart disease, examining the underlying causes, current understanding, and future directions for research.

The Evolving Landscape of HIV and CVD

Early in the AIDS epidemic, before the widespread use of ART, HIV-associated cardiomyopathy – a weakening of the heart muscle – was a primary cardiovascular concern, often linked to severe immune deficiency.¹ With the advent of ART, which effectively suppresses viral load and restores immune function, the nature of cardiac complications has shifted. The effects of HIV on the cardiovascular system are now more subtle, yet the overall incidence of CVD remains elevated in people living with HIV (PLWH).²

What Causes the Increased Risk?

Several factors contribute to the heightened risk of CVD in PLWH:

• Persistent Inflammation: Even with successful ART, a degree of immune activation and inflammation often persists. This chronic inflammation is a key driver of atherosclerosis – the buildup of plaque in the arteries – and other cardiovascular problems.⁴
• Traditional Risk Factors: PLWH may have a higher prevalence of traditional CVD risk factors like high blood pressure, high cholesterol, and diabetes.
• HIV-Specific Effects: HIV can directly affect the heart muscle and blood vessels, even in the absence of severe immune suppression.
• Antiretroviral Therapy: Some ART medications have been linked to metabolic changes, such as increased cholesterol levels, which can contribute to CVD risk.

Types of Cardiovascular Disease Seen in People with HIV

PLWH are at increased risk for a range of cardiovascular conditions, including:

• Coronary Artery Disease (CAD): Narrowing of the arteries that supply blood to the heart.
• Heart Failure: The heart’s inability to pump enough blood to meet the body’s needs.
• Cardiomyopathy: Disease of the heart muscle.
• Arrhythmias: Irregular heartbeats.
• Stroke: Disruption of blood flow to the brain.

Diagnosis and Monitoring

Early detection and management of CVD are crucial in PLWH. Advances in cardiac imaging, such as echocardiography, cardiac MRI, and CT angiography, allow for more accurate diagnosis and assessment of heart disease. Regular monitoring of cardiovascular risk factors is also essential.

Future Directions

Research continues to unravel the complex interplay between HIV and CVD. Key areas of investigation include:

• Understanding the mechanisms driving persistent inflammation in PLWH.
• Identifying novel biomarkers for early detection of CVD risk.
• Developing targeted therapies to reduce cardiovascular risk in this population.
• Further investigation into the long-term cardiovascular effects of different ART regimens.³

As people with HIV live longer, healthier lives thanks to ART, addressing the challenges of HIV-associated CVD will become increasingly important. A proactive approach to cardiovascular risk management is essential for improving the overall health and well-being of PLWH.